Report Description

India azithromycin market is expected to grow at a steady rate during the forecast period. The India azithromycin market is driven by the supportive government policies and schemes that are promoting the manufacturing and development of drugs, intermediates and active pharmaceutical ingredients in the country. This will not only improve the status of local manufacturers but also help India in becoming self-sufficient. Additionally, the widespread use of the drug in various conditions such as middle ear infections, sexually transmitted infections, pneumonia, Lyme disease, skin disorders and a range of respiratory infections & diseases is further expected to boost the demand through FY2026.

The India azithromycin market is segmented based on source, form, route of administration, distribution channel, application, end user, company and region. Based on distribution channel, the market can be split into online and offline. The offline channel is expected to dominate the market owing to the consumer preference for buying medicines from a pharmacy or drug store. The online segment is also expected to register significant growth over the next few years. This can be ascribed to the emergence of several online pharmacies and doorstep drug delivery e-commerce platforms in the country.

The major players operating in the India azithromycin market are Pfizer Limited, Lupin Limited, Aurobindo Pharma Limited, Alembic Pharmaceuticals, Jubilant Life Sciences Limited, Sandoz Private Limited, Century Pharmaceuticals Limited, Infinity Laboratories Pvt. Ltd., Anuh Pharma Ltd., Farmachem Life Pvt Ltd., Envee Drugs Pvt. Ltd. and others. Major companies are developing advanced technologies, receiving approvals from regulatory bodies and launching new products in order to stay competitive in the market. Other competitive strategies include mergers & acquisitions and new product developments. For instance, recently in February 2020, Aurobindo Pharma Limited received FDA approval for manufacturing azithromycin for dosage strength 250mg and 500mg.

Years considered for this report:

Historical Years: FY2016-FY2019

Base Year: FY2020

Estimated Year: FY2021

Forecast Period: FY2022–FY2026

Objective of the Study:

  • To analyze and estimate the market size of India azithromycin market from FY2016 to FY2019.
  • To estimate and forecast the market size of India azithromycin market from FY2020 to FY2026 and growth rate until FY2026.
  • To classify and forecast India azithromycin market based on source, form, route of administration, distribution channel, application, end user, company and regional distribution.
  • To identify dominant region or segment in the India azithromycin market.
  • To identify drivers and challenges for India azithromycin market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in India azithromycin market.
  • To identify and analyze the profile of leading players operating in India azithromycin market.
  • To identify key sustainable strategies adopted by market players in India azithromycin market.

Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of India azithromycin market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Azithromycin manufacturers/ suppliers/ distributors
  • Market research and consulting firms
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to azithromycin

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, India azithromycin market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • India Azithromycin Market, By Source:
    • In-House
    • Contract Manufacturing Organizations
  • India Azithromycin Market, By Form:
    • Tablet
    • Powder
    • Solution/Drops
  • India Azithromycin Market, By Route of Administration:
    • Oral
    • Injectable
    • Ophthalmic
  • India Azithromycin Market, By Distribution Channel:
    • Online
    • Offline
  • India Azithromycin Market, By Application:
    • Middle Ear Infections
    • Strep Throat, Pneumonia
    • Travelers Diarrhea
    • Sexually Transmitted Infections
    • Others
  • India Azithromycin Market, By End User:
    • Adult
    • Pediatric
  • India Azithromycin Market, By Region:
    • North
    • South
    • East
    • West

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in India azithromycin market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
India Azithromycin market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]  

Table of content

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Azithromycin Market

4.    Executive Summary

5.    Manufacturing Azithromycin

5.1.  Raw Material

5.2.  Machinery

5.3.  Manufacturing Methods

5.4.  Contact Details of Machinery & Raw Material Suppliers

6.    Pharmacodynamic Overview of Azithromycin

6.1.  Mechanism of Action

6.2.  Absorption

6.3.  Volume of Distribution

6.4.  Protein Binding

6.5.  Metabolism

6.6.  Route of Elimination

6.7.  Half-Life

6.8.  Clearance

6.9.  Toxicity

7.    India Azithromycin Market Outlook

7.1.  Market Size & Forecast

7.1.1.     By Value & Volume

7.2.  Market Share & Forecast

7.2.1.     By Source (In-house v/s Contract Manufacturing Organizations)

7.2.2.     By Form (Tablet, Powder, Solution/Drops)

7.2.3.     By Route of Administration (Oral, Injectable, Ophthalmic)

7.2.4.     By Distribution Channel (Online v/s Offline)

7.2.5.     By Application (Middle Ear Infections, Strep Throat, Pneumonia, Travelers Diarrhea, Sexually Transmitted Infections, Others)

7.2.6.     By End User (Adult v/s Pediatric)

7.2.7.     By Region (North, East, South, West)

7.2.8.     By Company

7.3.  Product Market Map

8.    Market Dynamics

8.1.  Drivers/Opportunities

8.2.  Challenges/Restraints

9.    Market Trends & Developments

10.  Policy & Regulatory Landscape

10.1.              Custom Duty & Taxes

10.2.              Government Subsidy & Benefits

10.3.              Relevant Policies & Regulations (GMP, USFDA, WHO Certifications)

11.  Import & Export Analysis

12.  Pricing Analysis

13.  India Economic Profile

14.  Competitive Landscape

14.1.              Company Profiles

14.1.1.  Pfizer Limited      Company Brief      Production Plants & Capacity      Financials (If Available)      Captive Consumption Vs Merchant Sale      Current & Future Plans

14.1.2.  Lupin Limited

14.1.3.  Aurobindo Pharma Limited

14.1.4.  Alembic Pharmaceuticals

14.1.5.  Jubilant Life Sciences Limited

14.1.6.  Sandoz Private Limited

14.1.7.  Century Pharmaceuticals Limited

14.1.8.  Infinity Laboratories Pvt. Ltd.

14.1.9.  Anuh Pharma Ltd.

14.1.10.                Farmachem Life Pvt Ltd.

14.1.11.                Envee Drugs Pvt. Ltd.

15.  Strategic Recommendations

16.  About Us & Disclaimer 

Figures and Tables

Frequently asked questions